Please ensure Javascript is enabled for purposes of website accessibility

Aerie Pharmaceuticals (AERI)

Nasdaq Global Market

Aerie Pharmaceuticals  Stock Quote
$16.51 $0.30 1.9%
Price as of June 18, 2021, 4:00 p.m. ET View Interactive AERI Charts

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company engaged in the discovery development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

Interactive Chart

News & Analysis: Aerie Pharmaceuticals


Market Moves


Is Aerie Pharmaceuticals a Buy?

Wall Street has given the eye-care specialist the cold shoulder in 2020. Is that an opportunity for individual investors?